Matt works closely with management teams across the Midlands looking to grow their business and is responsible for identifying ambitious teams that would benefit from the support of a private equity partner.

Since joining LDC in 2012, Matt has invested more than £300million across a number of high-profile businesses in the UK, including IWS Group, Kingswood ,The NEC Group, BioZone Scientific, Prism Medical, Stuart Turner, Eley, SMH Fleet, Centiq, Ross Trustees, Eley, and CitySprint, averaging over 3x return on realised investments.

Matt is currently Investor Director on the Boards of Kingswood Healthcare and Cardel and also sits on the UK & European Capital Committee for the BVCA which represents the interests of the BVCA’s mid-market members. Previous Board positions include Stuart Turner, Kee Safety, Prism Medical, and CitySprint.

Matt recently spoke with private equity news title Real Deals about LDC’s track record in the healthcare sector – read more here.

After graduating from Nottingham Trent University with a First Class Degree in Accounting & Finance and qualifying as a Chartered Accountant, Matt gained eight years of corporate finance experience with PwC and Alantra, working in the UK and North America.

Quote mark

LDC trusted my vision for the Stuart Turner group which gave me the platform and capital to execute on the M&A strategy. Matt was also right alongside me in the thick of the negotiations and deal assessment and the VCP team provided valuable pre and post deal integration support – it felt like a true team effort”.

Richard Harden, CEO
Stuart Turner

Round table report: Midlands deal specialists

LDC’s Matt Newbold and a panel of advisory specialists and businesses who had recently acquired others discuss how they see the next 12 months in the deals sector.

Read report
Round table report: Midlands deal specialists


Deal of the Year

SMH Fleet Solutions – Insider Midlands Dealmakers

Funder of the Year

Insider Midlands Dealmakers